col blocks we are bridge builder col blocks
COVID answers in Scientific Journals all over the world

Future Medicine: Future Microbiology
  original article Date Title Authors   All Authors
1 [GO] 2022―Jan―19 Scrub typhus in two COVID-19 patients: a diagnostic dilemma Chandan Kumar Thakur, Priyam Batra, EV Vinayaraj, K Sreenath, Nisha Rathor, Urvashi B Singh, et al. (+5)
2 [GO] 2022―Jan―19 Bucillamine in the treatment of patients with mild to moderate COVID-19: an interview with Michael Frank Michael Frank
3 [GO] 2021―Dec―17 Role of advanced respiratory support in acute respiratory failure in clinically frail patients with COVID-19 Iftikhar Nadeem, Louise Jordon, Masood Ur Rasool, Noor Mahdi, Ritesh Kumar, Zahra Rehman, et al. (+5)
4 [GO] 2021―Dec―17 Inflammation at the crossroads of Helicobacter pylori and COVID-19 Ileana Gonzalez, Cristian Lindner, Ivan Schneider, Miguel A Morales, Armando Rojas
5 [GO] 2021―Nov―23 Comparison of clinical, laboratory and radiological features in confirmed and unconfirmed COVID-19 patients Serkan Surme, Gulsah Tuncer, Betul Copur, Esra Zerdali, Inci Yilmaz Nakir, Meltem Yazla, et al. (+7)
6 [GO] 2021―Nov―23 Drug-based therapeutic strategies for COVID-19-infected patients and their challenges Khatereh Zarkesh, Elaheh Entezar-Almahdi, Parisa Ghasemiyeh, Mohsen Akbarian, Marzieh Bahmani, Shahrzad Roudaki, et al. (+5)
7 [GO] 2021―Nov―11 Current status of therapeutic approaches and vaccines for SARS-CoV-2 Braira Wahid, Anam Amir, Ayesha Ameen, Muhammad Idrees
8 [GO] 2021―Nov―10 Drug repurposing against SARS-CoV-1, SARS-CoV-2 and MERS-CoV Sarah Aherfi, Bruno Pradines, Christian Devaux, Stéphane Honore, Philippe Colson, Bernard La Scola, Didier Raoult
9 [GO] 2021―Oct―25 Potential role of marine species-derived bioactive agents in the management of SARS-CoV-2 infection Muhammad Asif, Mohammad Saleem, Hafiza Sidra Yaseen, Ashwaq HS Yehya, Malik Saadullah, Hafiz Muhammad Zubair, et al. (+4)
10 [GO] 2021―Oct―22 A comparative study of the mental health impact of the COVID-19 pandemic on health care professionals in India Jitender Jakhar, Partha Sarathi Biswas, Mahima Kapoor, Amandeep Panghal, Amit Meena, Harsha Fani, Pradip Kharya
11 [GO] 2021―Oct―07 Molecular characterization, phylogenetic and variation analyses of SARS-CoV-2 strains in Turkey Murat Karamese, Didem Ozgur, Emin E Tutuncu
12 [GO] 2021―Sep―01 Coronaviruses construct an interconnection way with ERAD and autophagy Aref Movaqar, Atieh Yaghoubi, SA Rahim Rezaee, Saeid A Jamehdar, Saman Soleimanpour
13 [GO] 2021―Sep―01 SARS-CoV-2: lessons from both the history of medicine and from the biological behavior of other well-known viruses Sirio Fiorino, Fabio Tateo, Dario De Biase, Claudio G Gallo, Paolo E Orlandi, Ivan Corazza, et al. (+8)
14 [GO] 2021―Jul―28 Relationship of D-dimer and prediction of pulmonary embolism in hospitalized COVID-19 patients: a multicenter study Iftikhar Nadeem, Asad Anwar, Louise Jordon, Noor Mahdi, Masood Ur Rasool, Jonathan Dakin, She Lok
15 [GO] 2021―Jul―28 Suboptimal antimicrobial stewardship in the COVID-19 era: is humanity staring at a postantibiotic future? Oloche Owoicho, Kesego Tapela, Alexandra Lindsey Djomkam Zune, Nora Nganyewo Nghochuzie, Abiola Isawumi, Lydia Mosi
16 [GO] 2021―Jul―05 Prevalence of COVID-19 in 10,000 samples from 7853 patients in Eastern Turkey by positive real-time PCR Murat Karamese, Didem Ozgur, Ceyda Tarhan, Susamber D Altintas, Okan Caliskan, Aysegul Tuna, et al. (+7)
17 [GO] 2021―Jun―24 Amuchina Gel Xgerm hand rub in vitro virucidal activity against SARS-CoV-2 Alessandra Capezzone de Joannon, Angela Testa, Natalie Falsetto, Michela Procaccini, Lorella Ragni
18 [GO] 2021―Jun―04 Clinical microbiology laboratories and COVID-19: an interview with Joseph Blondeau Joseph Blondeau
19 [GO] 2021―May―17 Preventing the next pandemic and tackling antiscience: an interview with Peter Hotez Peter Hotez
20 [GO] 2021―May―11 Metabolite reanalysis revealed potential biomarkers for COVID-19: a potential link with immune response Xin Chen, Mingli Gu, Tengda Li, Yi Sun
21 [GO] 2021―May―07 Glimpses into evolutionary trajectories of SARS-CoV-2: emerging variants and potential immune evasion routes Cleo Anastassopoulou, Yiannis Manoussopoulos, Vicky Lampropoulou, Athanasios Tsakris
22 [GO] 2021―Apr―13 Herd immunity: could it bring the COVID-19 pandemic to an end? Thomas Hugh Pennington
23 [GO] 2021―Apr―13 The interplay of SARS-CoV-2 and Clostridioides difficile infection Sahil Khanna, Colleen S Kraft
24 [GO] 2021―Mar―12 COVID-19 pneumonia: do not leave the corticosteroids behind! Simone Mornese Pinna, Silvia Scabini, Silvia Corcione, Tommaso Lupia, Francesco G De Rosa
25 [GO] 2021―Feb―11 Dual targeting of toll-like receptor 4 and angiotensin-converting enzyme 2: a proposed approach to SARS-CoV-2 treatment Laura Kate Gadanec, Tawar Qaradakhi, Kristen R McSweeney, Benazir Ali, Anthony Zulli, Vasso Apostolopoulos
26 [GO] 2021―Jan―25 COVID-19: it is all about sepsis Jean-Louis Vincent
27 [GO] 2021―Jan―19 Review of the use of nasal and oral antiseptics during a global pandemic Christopher Stathis, Nikolas Victoria, Kristin Loomis, Shaun A Nguyen, Maren Eggers, Edward Septimus, Nasia Safdar
28 [GO] 2021―Jan―18 The histo-blood group antigens of the host cell may determine the binding of different viruses such as SARS-CoV-2 Mayra Cuéllar-Cruz
29 [GO] 2021―Jan―06 Existing antiviral options against SARS-CoV-2 replication in COVID-19 patients Reza Ghanbari, Ali Teimoori, Anahita Sadeghi, Ashraf Mohamadkhani, Sama Rezasoltani, Ebrahim Asadi, et al. (+2)
30 [GO] 2021―Jan―06 Parallels in the pathogenesis of SARS-CoV-2 and M. tuberculosis: a synergistic or antagonistic alliance? Kesego Tapela, Charles Ochieng’ Olwal, Osbourne Quaye
31 [GO] 2020―Dec―22 COVID-19: mask efficacy is dependent on both fabric and fit Steven Darby, Krishnakumar Chulliyallipalil, Milosz Przyjalgowski, Paddy McGowan, Simon Jeffers, Alan Giltinan, et al. (+3)
32 [GO] 2020―Nov―24 Chloroquine/hydroxycloroquine and COVID-19: need to know more about Antonio Cassone, Licia Iacoviello, Roberto Cauda
33 [GO] 2020―Nov―20 The role of pharmaceutical nanotechnology in the time of COVID-19 pandemic Lígia N de M Ribeiro, Belchiolina B Fonseca
34 [GO] 2020―Nov―12 Effective optimization of SARS-CoV-2 laboratory testing variables in an era of supply chain constraints Nikhil S Sahajpal, Ashis K Mondal, Allan Njau, Sudha Ananth, Kimya Jones, Pankaj K Ahluwalia, et al. (+7)
35 [GO] 2020―Nov―06 Clinical microbiology laboratories and COVID-19: the calm before the storm Joseph M Blondeau
36 [GO] 2020―Nov―06 Risks of SARS-CoV-2 on male reproductive health and the practice of semen analysis and cryopreservation Michael B Yakass, Osbourne Quaye, Bryan J Woodward
37 [GO] 2020―Nov―03 Coronavirus pandemic: treatment and future prevention Kenneth Lundstrom
38 [GO] 2020―Oct―21 Systemic mycoses: a potential alert for complications in COVID-19 patients Gonzalo Segrelles-Calvo, Glauber R de S Araújo, Susana Frases
39 [GO] 2020―Oct―21 Mutation profile of over 4500 SARS-CoV-2 isolations reveals prevalent cytosine-to-uridine deamination on viral RNAs Yue Li, Xinai Yang, Na Wang, Haiyan Wang, Bin Yin, Xiaoping Yang, Wenqing Jiang
40 [GO] 2020―Sep―21 Potential alteration of COVID-19 by beta-mercaptoethanol Robert E Click
41 [GO] 2020―Sep―03 SARS-CoV-2 transmission, the ambiguous role of children and considerations for the reopening of schools in the fall Cleo Anastassopoulou, Nicholas Spanakis, Athanasios Tsakris
42 [GO] 2020―Aug―27 Pathogenesis, clinical manifestations and complications of coronavirus disease 2019 (COVID-19) Elaheh Kordzadeh-Kermani, Hossein Khalili, Iman Karimzadeh
43 [GO] 2020―Aug―26 Phages in the fight against COVID-19? Andrzej Górski, Ryszard Międzybrodzki, Maciej Żaczek, Jan Borysowski
44 [GO] 2020―Aug―14 Anal swab as the potentially optimal specimen for SARS-CoV-2 detection to evaluate the hospital discharge of COVID-19 patients Mei Sun, Dong Guo, Jing Zhang, Jian Zhang, Hai-Feng Teng, Jun Xia, et al. (+3)
45 [GO] 2020―Jul―17 COVID-19: in the absence of vaccination - ‘mask-the-nation’ Roy D Sleator, Steven Darby, Alan Giltinan, Niall Smith
46 [GO] 2020―Jul―14 N-acetylcysteine as a potential treatment for novel coronavirus disease 2019 Rangel-Méndez Jorge-Aarón, Moo-Puc Rosa-Ester
47 [GO] 2020―Jul―08 The use of radiological imaging alongside reverse transcriptase PCR in diagnosing novel coronavirus disease 2019: a narrative review Michael Naguib, Fathi Moustafa, Mustafa Thaer Salman, Nermin Kamal Saeed, Manaf Al-Qahtani
48 [GO] 2020―Jun―11 Focus on a 2019-novel coronavirus (SARS-CoV-2) Ling-Pu Zhang, Meixian Wang, Yanping Wang, Jun Zhu, Nannan Zhang


[de][en]

Last change 2022―Jan―26 16:55:12 UTC

© Daten-Quadrat 2022       Done in 0.010 sec